Gema Doménech

1.3k total citations
19 papers, 829 citations indexed

About

Gema Doménech is a scholar working on Molecular Biology, Neurology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gema Doménech has authored 19 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gema Doménech's work include Neuroblastoma Research and Treatments (3 papers), Cardiac Arrest and Resuscitation (3 papers) and Mechanical Circulatory Support Devices (3 papers). Gema Doménech is often cited by papers focused on Neuroblastoma Research and Treatments (3 papers), Cardiac Arrest and Resuscitation (3 papers) and Mechanical Circulatory Support Devices (3 papers). Gema Doménech collaborates with scholars based in Spain, United States and Germany. Gema Doménech's co-authors include Raquel Serrano, Laia Viladevall, Amparo Ruiz, Jesús Giraldo, Anna Barceló, Joaquı́n Ariño, Ferràn Torres, Jordi Monfort, Ingrid Möller and Eva Montané and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Gema Doménech

18 papers receiving 801 citations

Peers

Gema Doménech
Dong Hyun Kim South Korea
Meng Yang China
Dan Yi China
Hye One Kim South Korea
Se Kyoo Jeong South Korea
Gema Doménech
Citations per year, relative to Gema Doménech Gema Doménech (= 1×) peers Naoko Matsunaga

Countries citing papers authored by Gema Doménech

Since Specialization
Citations

This map shows the geographic impact of Gema Doménech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gema Doménech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gema Doménech more than expected).

Fields of papers citing papers by Gema Doménech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gema Doménech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gema Doménech. The network helps show where Gema Doménech may publish in the future.

Co-authorship network of co-authors of Gema Doménech

This figure shows the co-authorship network connecting the top 25 collaborators of Gema Doménech. A scholar is included among the top collaborators of Gema Doménech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gema Doménech. Gema Doménech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Matilla, Ana, José Luis Lledó, Marı́a Varela, et al.. (2022). Early nivolumab addition to regorafenib in patients with hepatocellular carcinoma progressing under first-line therapy (GOING trial), interim analysis and safety profile.. Journal of Clinical Oncology. 40(4_suppl). 428–428. 6 indexed citations
2.
Doménech, Gema, et al.. (2021). Shock mixto en paciente con infarto agudo de miocardio: intervenciones enfermeras. Enfermería Intensiva. 32(4). 230–237.
3.
Doménech, Gema, et al.. (2021). Mixed shock in patients with acute myocardial infarction: Nursing interventions. PubMed. 32(4). 230–237. 2 indexed citations
4.
López‐Sobrino, Teresa, et al.. (2021). High venous to arterial CO2 gap is related to cardiovascular death in cardiogenic shock. European Heart Journal Acute Cardiovascular Care. 10(Supplement_1). 1 indexed citations
5.
Boget, Teresa, Antonio Donaire, Estefanía Conde‐Blanco, et al.. (2020). External trigeminal nerve stimulation for drug resistant epilepsy: A randomized controlled trial. Brain stimulation. 13(5). 1245–1253. 33 indexed citations
6.
Montoya, Javier, Mercè Falip, Javier Aparicio, et al.. (2018). Retrospective study of perampanel efficacy and tolerability in myoclonic seizures. Acta Neurologica Scandinavica. 138(2). 122–129. 21 indexed citations
7.
Hochberg, Marc C., Johanne Martel‐Pelletier, Jordi Monfort, et al.. (2015). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Annals of the Rheumatic Diseases. 75(1). 37–44. 185 indexed citations
8.
García, Idoia, José Ríos, Gema Doménech, et al.. (2012). A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma. Clinical Cancer Research. 18(7). 2012–2023. 51 indexed citations
9.
Solà, Rosa, Rosa M. Valls, Josep Ribalta, et al.. (2012). Cocoa, Hazelnuts, Sterols and Soluble Fiber Cream Reduces Lipids and Inflammation Biomarkers in Hypertensive Patients: A Randomized Controlled Trial. PLoS ONE. 7(2). e31103–e31103. 38 indexed citations
10.
Cánovas, Manuel, et al.. (2012). Bioequivalence Study of 2 Orodispersible Formulations of Ondansetron 8 mg in Healthy Volunteers. Arzneimittelforschung. 62(2). 59–62. 2 indexed citations
11.
Cánovas, Manuel, et al.. (2011). Bioequivalence evaluation of two dosage forms of olanzapine 10 mg formulations in healthy volunteers. Arzneimittelforschung. 61(2). 75–79. 6 indexed citations
12.
Möller, Ingrid, Montserrat Pérez-Encinas, Jordi Monfort, et al.. (2010). Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study. Osteoarthritis and Cartilage. 18. S32–S40. 39 indexed citations
14.
Lavarino, Cinzia, Nai‐Kong V. Cheung, Idoia García, et al.. (2009). Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma. BMC Cancer. 9(1). 44–44. 25 indexed citations
15.
Vilaplana, Cristina, Eva Montané, Sergio Pinto, et al.. (2009). Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI®. Vaccine. 28(4). 1106–1116. 99 indexed citations
16.
Lavarino, Cinzia, Idoia García, Carlos Mackintosh, et al.. (2008). Differential expression of genes mapping to recurrently abnormal chromosomal regions characterize neuroblastic tumours with distinct ploidy status. BMC Medical Genomics. 1(1). 36–36. 10 indexed citations
17.
Morell, Ferrán, Leonardo Reyes, Gema Doménech, et al.. (2008). Diagnósticos y procedimientos en 500 pacientes consecutivos con sospecha clínica de enfermedad pulmonar intersticial. Archivos de Bronconeumología. 44(4). 185–191. 31 indexed citations
18.
Morell, Ferrán, Leonardo Reyes, Gema Doménech, et al.. (2008). Diagnoses and Diagnostic Procedures in 500 Consecutive Patients With Clinical Suspicion of Interstitial Lung Disease. Archivos de Bronconeumología. 44(4). 185–191. 24 indexed citations
19.
Viladevall, Laia, Raquel Serrano, Amparo Ruiz, et al.. (2004). Characterization of the Calcium-mediated Response to Alkaline Stress in Saccharomyces cerevisiae. Journal of Biological Chemistry. 279(42). 43614–43624. 180 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026